Therapeutic Landscape of Carfilzomib and Other Modulators of the Ubiquitin-Proteasome Pathway

Documenti analoghi

• Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications
  di: Huang, Qian, et al.
  Pubblicazione: (2010)
• The Ubiquitin-Proteasome Pathway and Proteasome Inhibitors
  di: Myung, Jayhyuk, et al.
  Pubblicazione: (2001)
• The ubiquitin-proteasome pathway in cancer.
  di: Spataro, V., et al.
  Pubblicazione: (1998)
• Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma
  di: Kuhn, Deborah J., et al.
  Pubblicazione: (2007)
• Activin-β(C) modulates cachexia by repressing the ubiquitin-proteasome and autophagic degradation pathways
  di: Marino, Francesco Elia, et al.
  Pubblicazione: (2015)